General Information of the Compound
| Compound ID |
CP0069674
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-Dipropylsulfamoyl-benzoic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-((Dipropylamino)sulfonyl)benzoic acid;4-(Di-n-propylsulfamoyl)benzoesaeure
4-(Dipropylsulfamoyl)benzoic acid
4-(N,N-Dipropylsulfamoyl)benzoesaeure
4-[(dipropylamino)sulfonyl]benzoic acid
Apurina
Bencid
Benecid
Benemid
Benemid (TN)
Benemide
Benuryl
Benuryl (TN)
Biokanol Brand of Probenecid
Col-BENEMID
ColBenemid (co mponent of)
ColBenemid (component of)
ICN Brand of Probenecid
IDIS Brand of Probenecid
Major Brand of Probenecid
Martec Brand of Probenecid
Merck Brand of Probenecid
Ophthalmic Brand of Probenecid
P-(Dipropylsulfamoyl)benzoic acid
P-(Dipropylsulfamyl)benzoic acid
P-[Dipropylsulfamoyl]benzoic acid
Panuric
Parabenem
Parmed Brand of Probenecid
Polycillin-BRB
Polycillin-PRB (component of)
Pro-Cid
Probalan
Probampacin
Probecid
Proben
Probenecid
Probenecid (JP15/USP/INN)
Probenecid Major Brand
Probenecid Martec Brand
Probenecid Parmed Brand
Probenecid Weimer
Probenecid Zenith Brand
Probenecid [INN:BAN:JAN]
Probenecid acid
Probenecida
Probenecida [INN-Spanish]
Probenecide
Probenecide [INN-French]
Probenecidum
Probenecidum [INN-Latin]
Probenemid
Probenicid
Probenid
Probexin
Prolongine
Robenecid
Sulprin
Synergid R
Tubophan
Uricosid
Urocid
Valdecasas Brand of Probenecid
Zenith Brand of Probenecid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H19NO4S
|
||||||||||||||||||
| Molecular Weight |
285.365
|
||||||||||||||||||
| Canonical SMILES |
CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)
Show/Hide
|
||||||||||||||||||
| InChIKey |
DBABZHXKTCFAPX-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
57-66-9
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06258, Organic anion transporter 3
Protein ID: PT02209, Organic anion transporter 3
Protein ID: PT05092, Organic anion transporter 3
Protein ID: PT04064, Solute carrier family 22 member 6
Protein ID: PT06061, Solute carrier family 22 member 6
Protein ID: PT06135, Solute carrier organic anion transporter family member 1A1
Protein ID: PT06133, Solute carrier organic anion transporter family member 1A4
Clinical Information about the Compound